Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Behavioral Risk Factor Surveillance System (BRFSS) 2015 Cognitive Decline Module

Frequently Asked Questions

 

Why was the module developed?

In 2007, the CDC Healthy Aging Program—in collaboration with national experts—developed a 10-question Behavioral Risk Factor Surveillance System (BRFSS) module to measure self-reported increased confusion or memory loss and its associated effect. CDC developed these survey questions because of the importance of cognitive impairment as a public health issue, and the recommendation to develop population-based surveillance in The Healthy Brain Initiative: A National Public Health Road Map to Maintaining Cognitive Health [PDF–2.6M]. CDC consulted with a national panel of experts to develop the items.

CDC selected the BRFSS because of its long history helping states survey US adults about a wide range of behaviors that affect their health. The primary focus of the BRFSS are behaviors and conditions that are associated with the leading causes of death—heart disease, cancer, stroke, accidents, Alzheimer’s disease, and diabetes—and other important health issues.

Several actions in The Healthy Brain Initiative: The Public Health Road Map for State and National Partnerships, 2013–2018 [PDF–2.1M], focus on the BRFSS Cognitive Decline module.1

Top of Page

What do the questions in the module measure?

The questions measure the BRFSS respondents’ perceptions about any confusion or memory loss (in the past 12 months) that is happening more often or is getting worse, which captures cognitive decline that is more frequent or worse over time. If a respondent answers "yes" to this question, other questions from the module are asked to help understand whether increased confusion or memory loss, or ICML, affects functioning. These questions address how often ICML causes individuals to give up household chores or activities outside the home, whether they need assistance and get the help they need, and whether anyone has discussed ICML with a health care professional.

Because the questions are not trying to measure whether the person has a medical condition or diagnosis, we encourage that the measure be referred to as self-reported ICML.

View the 2015 BRFSS Cognitive Decline module [PDF–90K].

Top of Page

What can the data from the module tell us?

The module can provide the following state-level data leading to valuable insights:

  • Percentage of adults aged 45 years or older who experience increased confusion or memory loss (ICML).
  • Percentage of adults aged 45 years or older who experience difficulties with daily activities due to ICML.
  • Characteristics of adults aged 45 years or older who experience ICML.
  • Health conditions and behaviors of adults aged 45 years or older experiencing ICML (respondent-level data can be linked to other BRFSS measures such as health insurance and chronic conditions).
  • Percentage of adults aged 45 years or older who experience ICML and live alone.
  • Reported need for assistance due to ICML and whether individuals receive the help they need.
  • Relationship to other behavioral health factors from the BRFSS core.

Top of Page

Why is this module important for states and communities?

Declines in cognitive function vary among people and can include changes in attention, memory, learning, executive function (the ability to perform activities such as planning, organizing, paying attention, and remembering details), activities of daily living, and language capabilities that negatively affect quality of life, personal relationships, and the capacity for making informed decisions about health care and other matters.2 Memory problems are typically one of the first warning signs of cognitive decline, possibly because of the development of Alzheimer’s disease or a related dementia.3 Some causes of cognitive decline are reversible (i.e., depression, infections, medication side effects, nutritional deficiencies), but they can be serious and should be treated by a health care provider as soon as possible.2

There is increased attention and greater public health awareness about Alzheimer’s disease and related disorders.3 States and communities need to know about such conditions for medical and personal planning. They can have devastating effects on individuals and societies, including increased health care and long-term care needs as well as major caregiving and financial challenges.

Top of Page

What steps were taken to develop the module?

A multi step process was used to develop the questions for the module. A scientific literature review was conducted to identify existing surveys and questions that measure cognitive decline and impairment (http://www.ncbi.nlm.nih.gov/pubmed/19525214). Next, a panel of subject matter experts reviewed questions used on other surveys, adapted existing questions, and developed a set of possible questions for the module. The module was finalized after four rounds of cognitive testing and field testing in California's BRFSS survey during fall 2008. In 2009, five states (CA, FL, IA, LA, and MI) pilot-tested the module in their BRFSS surveys.

From 2011-2013, a total of 47 states and territories added the module (as an official optional module in 2011 and as state-added questions in 2012 and 2013). CDC consulted with data users and convened a panel to revise the module based on feedback. The revised 2015 module underwent two rounds of cognitive testing before it was finalized and approved by BRFSS coordinators to be included as an official optional module in the 2015 BRFSS.

Top of Page

How was the module updated for the 2015 BRFSS?

The BRFSS 2015 Cognitive Decline module includes the following revisions based on feedback from data users:

  • The module is shortened from 10 to 6 questions, on the basis of feedback to shorten the module.
  • The module is asked to BRFSS respondents aged 45 years or older, on the basis of previous data indicating this age group is more likely to answer “yes” to the index question than those younger than 44 years.
  • The name of the module is changed to the Cognitive Decline module to better reflect the measure.
  • The introductory text is edited to provide greater clarity based on feedback from the cognitive testing.

Top of Page

What states have used the module to date?

A total of 47 states or territories included the previous version of the module in their BRFSS to date.

  • In 2009, the following 5 states pilot tested the module: Florida, Louisiana, Michigan, California, and Iowa.
  • In 2011, the following 21 states included the module as an official optional module: Arkansas, California, Florida, Hawaii, Illinois, Iowa, Louisiana, Maryland, Michigan, Nebraska, New Hampshire, New York, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Utah, Washington, West Virginia, and Wisconsin. Georgia added the module as state-added questions.
  • In 2012, the following 24 states or territories included the module as state-added questions: Alabama, Arizona, Arkansas, California, Connecticut, District of Columbia, Georgia, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Mississippi, Missouri, Nevada, New Jersey, North Dakota, Ohio, Oregon, Virginia, West Virginia, Wisconsin, and Wyoming.
  • In 2013, the following 20 states or territories added the module as an optional module: Alaska, Arizona, Arkansas, Georgia, Idaho, Illinois, Indiana, Kansas, Massachusetts, Michigan, Minnesota, Nevada, New Mexico, New York, Oregon, Puerto Rico, South Dakota, Texas, Vermont, Virginia.

View the previous module [PDF–90K] version.

Top of Page

Are there considerations to take into account when reporting these data?

It is important to understand that any measure of increased confusion or memory loss, or ICML, obtained from the BRFSS is meant for public health purposes to help describe the problems associated with ICML in states and communities. Thus, it is not appropriate to compare with other measures of cognitive decline or cognitive impairment.

Because questions are self-reported and not designed to assess whether or not the person has a medical condition or a medical diagnosis, the data are not intended to be reported as a prevalence measure of a medical condition.

It is important to remember that the BRFSS is used to survey households and does not include residents of nursing homes, group homes, or other facilities. In addition, if the selected respondent is unable to respond to the survey because of physical or mental problems, the entire household is removed from the sample. Thus, respondents who complete the survey have been deemed by themselves or another household member to be mentally fit to respond to the survey.

Cell phone data were included for the first time in 2011, but states may opt to not ask optional modules on administered cell phone surveys. For states that added the module in 2011-2013, cell phones are considered a household of one for purposes of analyses.

Top of Page

Where can I get more information?

It is recommended that researchers not familiar with BRFSS data analyses become familiar with the methods unique to BRFSS, including weighting and raking methods. More information can be found at CDC’s BRFSS site. An Analytical Guidance document is available by contacting your state BRFSS coordinator or the Healthy Aging Program for more information.

Top of Page

References

  1. Alzheimer’s Association and Centers for Disease Control and Prevention. The Healthy Brain Initiative: The Public Health Road Map for State and National Partnerships, 2013–2018. Chicago, IL: Alzheimer’s Association; 2013.
  2. Wagster MV, King JW, Resnick SM, Rapp PR. The 87% guest editorial. J Gerontol A Biol Sci Med Sci. 2012;67(7):739-740.
  3. National Institute on Aging. Alzheimer's Disease Fact Sheet. Bethesda, MD: National Institutes of Health, US Dept of Health and Human Services; 2013. http://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-fact-sheet. Accessed October 16, 2014.
  4. US Department of Health and Human Services. National Plan to Address Alzheimer's Disease. Washington, DC: US Dept of Health and Human Services; 2014. http://aspe.hhs.gov/daltcp/napa/natlplan.pdf [PDF–984K]. Accessed October 16, 2014.

Top of Page

 

 

Contact Us:
  • Centers for Disease Control and Prevention
    Healthy Aging Program
    4770 Buford Highway, N.E., Mailstop F-78
    Atlanta, GA 30341-3717
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    8am-8pm
    ET/Monday-Friday
    Closed Holidays
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO